The Western States Scientific Safety Review Workgroup (WSSSRW) has recommended that a Pfizer COVID-19 booster dose be made available to children ages 5-11 at least five months after receiving the last dose in their primary vaccine series. The decision comes after the U.S. Food and Drug Administration (FDA) authorized and the Centers for Disease Control and Prevention (CDC) recommended a booster dose for children ages 5-11.

Boosters are now available for children 5-11.